Skip to main content

Table 3 Insulin regimen at initiation and at 1-year follow-up

From: Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study

Insulin regimen

At insulin initiation (N = 511)

1-year follow-up (N = 488)

N (%)

Mean dose ± SD (Unit)

N (%)

Mean dose ± SD (Unit)

Basal

32 (6.3%)

7.2 ± 2.9

35 (7.2%)

11.0 ± 4.5

Basal + short-acting

134 (26.2%)

Basal: 5.0 ± 2.5 Short: 14.9 ± 6.9

84 (17.2%)

Basal: 10.2 ± 8.4 Short: 19.4 ± 8.0

Short-acting

130 (25.4%)

12.8 ± 8.0

54 (11.1%)

17.6 ± 10.3

Premix

188 (36.8%)

12.3 ± 7.3

230 (47.1%)

20.4 ± 11.5

Others

27 (5.3%)

-

58 (11.9%)

-

No insulin

0

-

27 (5.5%)

-